#VoltPFA Webinar Series

  • Published:  06 June 2025
  • Likes: 

    Heart Icon

    2

Up Next

#VoltPFA Webinar Series

  • Published:  06 June 2025
  • Likes: 

    Heart Icon

    2

Average (ratings)
No ratings
Your rating
About the episode

In the second part of the video series, Dr Verma explored the Volt™ PFA System, highlighting its unique lesion assessment capabilities and versatile workflow. He discussed recent advancements in lesion strategy, focusing on the system's precision and the ability to tailor procedures to individual patient needs. Dr Verma also reviewed emerging clinical evidence, including the system's impact on efficacy, safety, and procedural efficiency.

Overview

The #VoltPFA Webinar Series explores the Volt™ Pulsed Field Ablation (PFA) system, offering insights into its clinical data, workflow innovations, and procedural advantages. Expert faculty discuss the system’s safety, efficacy, and low haemolysis rates, as well as the benefits of single-catheter workflows for real-time mapping and ablation. The series also covers the Volt system’s versatility in ablation across various anatomical targets, focusing on its role in simplifying atrial fibrillation (AF) ablation and procedural optimisation.

 

This webinar is supported by an independent educational grant from Abbott

More from this programme

Faculty Biographies

Atul Verma

Atul Verma

Director of Cardiology

Dr Atul Verma is currently Director of Cardiology at the McGill University Health Centre & McGill University, Montreal, CA.

Specialising in complex arrhythmias like atrial fibrillation and ventricular tachycardia, he has published over 300 peer-reviewed articles including in The New England Journal of Medicine. Dr Verma has co-chaired the Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee and contributed to the HRS/EHRA Consensus Document on Catheter Ablation of Atrial Fibrillation. He currently leads and participates in multiple international clinical trials.

View full profile